Hi Guest
X
Real-Time Quote
Enter Company or MFGlaxoSmithKline Pharmaceuticals Ltd. - Research Center
Results |
Quarterly
|
Statement | |
More |
(Rs crore)
Quarterly results in brief
| Sep ' 09 | Jun ' 09 | Mar ' 09 | Dec ' 08 | Sep ' 08 | |
|---|---|---|---|---|---|
| Sales | 518.28 | 461.95 | 460.98 | 374.87 | 463.71 |
| Operating profit | 195.29 | 167.44 | 168.37 | 111.19 | 176.41 |
| Interest | -16.84 | -19.39 | - | -29.76 | -15.09 |
| Gross profit | 212.13 | 204.83 | 194.58 | 141.61 | 201.77 |
| EPS (Rs) | 16.66 | 14.68 | 16.91 | 24.61 | 15.58 |
Quarterly results in details
| Sep ' 09 | Jun ' 09 | Mar ' 09 | Dec ' 08 | Sep ' 08 | |
|---|---|---|---|---|---|
| Other income | - | 18.00 | 26.21 | 0.66 | 10.27 |
| Stock adjustment | -0.44 | -8.22 | 9.25 | -25.71 | 17.68 |
| Raw material | 105.07 | 97.89 | 87.34 | 110.28 | 65.23 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 56.16 | 52.89 | 43.47 | 42.52 | 44.43 |
| Excise | -0.75 | 0.64 | -2.65 | -1.09 | -0.97 |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 162.95 | 151.31 | 155.20 | 137.68 | 160.93 |
| Provisions made | - | - | - | - | - |
| Depreciation | 3.99 | 3.96 | 3.67 | 4.73 | 4.00 |
| Taxation | 67.06 | 69.21 | 65.48 | 47.72 | 65.80 |
| Net profit / loss | 141.08 | 124.35 | 143.27 | 208.47 | 131.97 |
| Extra ordinary item | - | -7.31 | 17.84 | 119.31 | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 84.70 | 84.70 | 84.70 | 84.70 | 84.70 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | 417.86 | 417.86 | 417.86 | 417.86 | 417.86 |
| Agg.of non promotoholding (%) | 49.30 | 49.30 | 49.30 | 49.30 | 49.30 |
| OPM (%) | 37.68 | 36.25 | 36.52 | 29.66 | 38.04 |
| GPM (%) | - | 42.68 | 39.94 | 37.71 | 42.57 |
| NPM (%) | - | 25.91 | 29.41 | 55.51 | 27.84 |